Three sub-10 nm platinum nanoparticles (PtNPs) with distinctive morphologies were developed by using cucurbit[6]uril (CB[6]) as stabilizing agent and support. Both the size and shape of the PtNPs were simultaneously controlled by tuning the reducing agents. The prepared NPs have been comprehensively characterized by X-ray diffraction, X-ray photoelectron spectroscopy, transmission electron microscopy, and cyclic voltammetry. On account of the presence of CB[6] and its unique structural features, the as-prepared PtNPs are homogeneous in morphologies and exhibit higher activities toward methanol electrooxidation than commercial Pt/C. CB[6] has the ability to bind small molecules that can promote CO oxidation, therefore, all the three PtNPs showed enhanced poisoning tolerance. Such unique abilities of CB[6] can even promote the poisoning tolerance of commercial Pt/C through simple physical mixing.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: